NovaDel Initiates Pilot Study in Humans of a Faster Acting Version of the Leading Migraine Remedy Announcement Covers Second of Five Products Scheduled for Testing in Humans This Year LONDON, May...
American Stock Exchange Lists Common Stock of NovaDel Pharma Inc. NEW YORK, May 11 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of NovaDel Pharma Inc...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.7998 | 5.87015087964 | 30.6602 | 36.85 | 30.59 | 1465050 | 34.68611749 | SP |
4 | 4.25 | 15.0655795817 | 28.21 | 36.85 | 27.9388 | 1378493 | 32.0575178 | SP |
12 | -9.04 | -21.7831325301 | 41.5 | 48 | 25.74 | 14409179 | 35.48778532 | SP |
26 | -12.04 | -27.0561797753 | 44.5 | 84.47 | 25.74 | 28147070 | 49.75644834 | SP |
52 | -515.79 | -94.0793433653 | 548.25 | 574 | 25.74 | 17151208 | 57.60369681 | SP |
156 | -570.04 | -94.6124481328 | 602.5 | 786.355 | 25.74 | 12871805 | 57.98150015 | SP |
260 | -570.04 | -94.6124481328 | 602.5 | 786.355 | 25.74 | 12871805 | 57.98150015 | SP |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約